Skip to main content

Table 8 SF - 36 Physical function scores by group and visit

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

   

Group

P value(Between Groups)

   

UP446 250

mg/day

UP446 500

mg/day

Celecoxib

200 mg/day

Placebo

 

Visit

Baseline

Mean

19.53

19.93

21.07

19.40

0.170

  

Std

Deviation

1.88

2.15

2.19

2.61

 
 

30 Days

Mean

26.73

27.00

27.00

20.67

0.001

  

Std

Deviation

1.49

1.07

2.08

1.72

 
 

60 Days

Mean

27.21

26.77

27.31

21.15

0.001

  

Std

Deviation

1.31

1.92

1.44

2.08

 
 

90 Days

Mean

26.36

27.23

25.92

20.23

0.001

  

Std

Deviation

1.01

1.54

1.00

1.79

 
Back to article page

Nutrition Journal

ISSN: 1475-2891

Contact us